Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway

Tert-butylhydroquinone (tBHQ), an Nrf2 activator, has demonstrated neuroprotection against brain trauma and ischemic stroke in vivo. However, little work has been done with respect to its effect on early brain injury (EBI) after subarachnoid hemorrhage (SAH). At the same time, as an oral medication,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhong, Ji, Chengyuan, Wu, Lingyun, Qiu, Jiaoxue, Li, Qi, Shao, Zhong, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029824/
https://www.ncbi.nlm.nih.gov/pubmed/24848277
http://dx.doi.org/10.1371/journal.pone.0097685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029824/
https://www.ncbi.nlm.nih.gov/pubmed/24848277
http://dx.doi.org/10.1371/journal.pone.0097685

Ejemplares similares